Skip to main content

Molecular Therapy

  • ISSN: 1525-0016

Next planned ship date: June 6, 2024

  • 5 Year impact factor: 12.6
  • Impact factor: 12.4

Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-… Read more

Subscription options

Next planned ship date:
June 6, 2024

Institutional subscription on ScienceDirect

Request a sales quote


Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.

Visit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home